1-7 of 7
Thomas M. Moehler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Significance Of Parameters Of Dynamic Contrast-Enhanced MRI Detecting Increased Bone Marrow Microcirculation In Monoclonal Plasma Cell Disorders

Jens Hillengass, MD, Judith Ritsch, Maximilian Merz, MD, Hartmut Goldschmidt, MD, Christina Kunz, PhD, Barbara Wagner-Gund, Anthony Ho, MD, Thomas M. Moehler, MD, Stefan Delorme, MD
Journal: Blood
Blood (2013) 122 (21): 3146.
https://doi.org/10.1182/blood.V122.21.3146.3146
Published: 2013
Journal Articles

Comparison of Autologous and Allogeneic Transplantation As Therapy of First Relapse in Patients with Multiple Myeloma - Long-Term Follow up Analysis,

Ute Hegenbart, MD, Stefan O Schonland, MD, Axel Benner, Christina Wunder, Thomas M. Moehler, PD, Dr., Jens Hillengass, Martin Görner, Jana Schlenzka, Kai Neben, MD, Peter Dreger, Anthony D. Ho, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2011) 118 (21): 4124.
https://doi.org/10.1182/blood.V118.21.4124.4124
Published: 2011
Journal Articles

OPTIMUM Dose of Thalidomide for Relapsed Multiple Myeloma.

Martin Kropff, Honorata Giongco Baylon, MD, Jens Hillengass, MD, Tadeusz Robak, Roman Hajek, MD, Peter Liebisch, MD, Stefan Goranov, MD, Cyrille Hulin, Joan Blade, Tomaso Caravita, Herve Avet-Loiseau, MD, PhD, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, MD, Robert Zerbib, Thierry Facon
Journal: Blood
Blood (2009) 114 (22): 959.
https://doi.org/10.1182/blood.V114.22.959.959
Published: 2009
Journal Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

Jens Hillengass, Christian M Zechmann, Tobias Bäuerle, Christiane Heiss, Axel Benner, Kai Neben, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Stefan Delorme, Thomas M. Moehler
Journal: Blood
Blood (2008) 112 (11): 2704.
https://doi.org/10.1182/blood.V112.11.2704.2704
Published: 2008
Journal Articles

Imexon (AOP 99.0001) for Treatment of Relapsed or Refractory Multiple Myeloma: A Phase I/II Study

Thomas M. Moehler, Anatoli Golenkov, MD, Heinz Ludwig, Martin H Kropff, Nuriet K Khuageva, E. A Osmanov, I. Broen, MD, H. Goldschmidt
Journal: Blood
Blood (2008) 112 (11): 5195.
https://doi.org/10.1182/blood.V112.11.5195.5195
Published: 2008
Journal Articles

Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma

Clinical Trials & Observations Brief Report
Kai Neben, Joannis Mytilineos, Thomas M. Moehler, Astrid Preiss, Alwin Kraemer, Anthony D. Ho, Gerhard Opelz, Hartmut Goldschmidt
Journal: Blood
Blood (2002) 100 (6): 2263–2265.
https://doi.org/10.1182/blood.V100.6.2263
Published: 2002
Journal Articles

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

Clinical Trials & Observations Brief Report
Thomas M. Moehler, Kai Neben, Axel Benner, Gerlinde Egerer, Fatime Krasniqi, Anthony D. Ho, Hartmut Goldschmidt
Journal: Blood
Blood (2001) 98 (13): 3846–3848.
https://doi.org/10.1182/blood.V98.13.3846
Published: 2001